EqFP578 Mutants for Red Fluorescence and Reduced Aggregation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current fluorescent proteins, such as GFP, have limitations in terms of spectral diversity and suitability for various research applications, necessitating the development of novel fluorescent proteins with improved properties.

Innovation Solution

The isolation and genetic engineering of nucleic acid molecules encoding the Entacmaea quadricolor fluorescent protein EqFP578 and its mutants, which offer enhanced folding, reduced aggregation and oligomerization, and altered spectral characteristics, are provided. These mutants include specific amino acid substitutions that improve protein stability and fluorescence intensity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If GFP and its mutants are used as fluorescent markers, then fluorescence intensity is achieved, but spectral diversity is limited

Engineering Contradiction:
Improvefluorescence intensityVSAvoidspectral diversity
Core Design Contradiction:
Illumination intensityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by systematically modifying amino acid residues at positions 65, 148, and 203 to generate fluorescent proteins with different spectral properties. Specific substitutions (e.g., S65T, Y148F, H203Y) shift excitation and emission wavelengths, creating cyan, green, yellow, and red fluorescent variants from a single ancestral GFP sequence, thus achieving spectral diversity while maintaining fluorescence intensity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by making targeted amino acid substitutions at specific positions within the GFP sequence rather than random mutations. Each position (65, 148, 203) is specifically modified to control different aspects of fluorescence: position 65 affects quantum yield and excitation wavelength, position 148 influences emission wavelength and photostability, and position 203 controls spectral shape and brightness, allowing precise control over fluorescent properties

Inventive Principle:
Principle #3Local quality

2Illumination intensity

If wild-type EqFP578 is expressed, then red fluorescence is achieved, but aggregation and oligomerization occur

Engineering Contradiction:
Improvered fluorescenceVSAvoidprotein aggregation
Core Design Contradiction:
Illumination intensityVSStability of the object's composition

Solution Approach 1:

The patent applies the taking out principle by removing problematic amino acid residues from the wild-type EqFP578 sequence that promote aggregation and oligomerization. Specific residues involved in intermolecular interactions are eliminated or replaced, extracting the aggregation-prone properties while retaining the red fluorescent chromophore functionality, resulting in monomeric fluorescent proteins suitable for imaging applications

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies this principle by creating simplified, engineered versions of EqFP578 that sacrifice some native structural features responsible for aggregation but gain improved solubility and monomeric behavior. The engineered variants use reduced amino acid sequences or modified terminal regions that prevent oligomerization while maintaining sufficient fluorescence for practical use, effectively replacing the problematic wild-type protein

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If traditional GFP variants are used, then green fluorescence is achieved, but suitability for multi-color imaging is reduced

Engineering Contradiction:
Improveease of useVSAvoidmulti-color imaging capability
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent applies universality by developing a family of fluorescent proteins from a single GFP ancestor that can perform multiple spectral functions. By systematically varying amino acid substitutions at key positions, the invention creates cyan, green, yellow, and red fluorescent variants that can be used individually or in combination for multi-color imaging, allowing a single genetic construct system to achieve versatile spectral applications

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent applies segmentation by dividing the spectral range into distinct segments (cyan, green, yellow, red) achieved through specific amino acid substitutions. Each substitution combination creates a fluorescent protein optimized for a particular spectral segment, allowing researchers to select and combine specific variants for multi-color imaging experiments, effectively segmenting the fluorescence spectrum into usable modules

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered fluorescent proteins exhibit improved folding, faster chromophore maturation, reduced aggregation, and altered spectral properties, making them suitable for advanced biological imaging and research applications.

Implementation Method 1

Fluorescent proteins are proteins that exhibit fluorescence upon irradiation with light of the appropriate excitation wavelength

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS8563703B2Fluorescent proteins and methods for using same
Publication Date: 2013.10.22 EVROGEN IP
  • US8563703B2 patent drawing
  • US8563703B2 patent drawing
  • US8563703B2 patent drawing

AI summary

The present invention provides nucleic acid molecules encoding novel red fluorescent proteins from Entacmaea quadricolor and mutants thereof. Also of interest are proteins that are substantially similar to the novel red fluorescent proteins. In addition, host cells, stable cell lines and transgenic organisms comprising the nucleic acid molecules encoding the novel red fluorescent proteins are provided. The subject proteins and nucleic acid compositions find use in a variety of different applications and methods, particularly for labeling of biomolecules, cells, or cell organelles. Finally, kits for use in such methods and applications are provided.